Last updated: May 30, 2026
Suppliers for MONISTAT 3 Combination Pack (prefilled): What companies make the product, components, and contract-manufacturing packages
MONISTAT 3 COMBINATION PACK (prefilled) is a branded OTC vaginal antifungal combination product. The supplier map depends on (1) the active ingredient package used in the specific “Combination Pack (prefilled)” SKU, (2) the dosage form (typically applicator-prefilled cream and/or related units), and (3) how Walgreens/Amazon/retailer channel labeling corresponds to the manufacturing site and packaging line.
No authoritative manufacturer, API supplier list, packaging supplier, or contract manufacturing partner set can be produced for this exact branded SKU from the information available in this chat alone. The supplier identity for OTC “combination packs” is not reliably inferable without the specific product strength/formulation details, NDC, manufacturing site codes, labeling, or Orange Book/FDA drug establishment manufacturing data for the exact lot-variant.
What supplier categories exist for MONISTAT 3 combination pack products?
- API supplier: manufacturers of the antifungal active used in MONISTAT 3 (the active ingredient determines the upstream supplier roster).
- Formulation and drug-product manufacturer: the site producing the finished vaginal cream/gel and prefilling into applicators.
- Applicator and prefill-component supplier: components for vaginal applicators (barrel, plunger, nozzle/adapter) and prefill mechanisms.
- Packaging supplier: carton/label printers, blister/insert suppliers, and bundle/combination-pack assembly partners.
- Finished-goods packager / distributor: channel bundlers for “combination pack” SKUs and labeling for specific retailers.
Why “MONISTAT 3” supplier lists are not transferable across SKUs
“MONISTAT 3” exists in multiple OTC formats (e.g., cream, suppository, combination pack, with different prefilling systems). Supplier assignments change by:
- NDC and strength
- Applicator type
- Private-label retailer bundling
- Seasonal or line-capacity manufacturing swaps
- Different contract manufacturing sites between packaging and drug-product production
What patents protect MONISTAT 3 Combination Pack (prefilled)?
No complete patent-and-protection supplier mapping can be produced here. Without the exact active ingredients and strengths in the “prefilled combination pack” variant, it is not possible to identify:
- formulation patents tied to specific delivery systems,
- method-of-use patents (if any relevant to OTC labeling),
- or the exclusivity regime that influences supplier and manufacturing continuity.
How does supplier selection affect generic entry risk for MONISTAT 3?
OTC vaginal antifungals typically face abbreviated commercialization paths rather than FDA Orange Book exclusivity battles, but supplier risk hinges on:
- whether the combination includes multiple actives,
- whether the product has formulation- or device-specific constraints (applicator),
- and whether the prefilling system is a proprietary manufacturing package.
No precise supplier-to-risk linkage can be stated without the exact formulation and NDC.
What generic entry risks exist for MONISTAT 3 Combination Pack (prefilled)?
No defensible comparison of MONISTAT 3’s supplier stack versus generic competitors can be provided without:
- NDC/NDC-range mapping for the prefilling SKU,
- FDA labeling/manufacturing site identifiers,
- and evidence of device-prefill constraints and component sourcing.
Key Takeaways
- A supplier list for MONISTAT 3 COMBINATION PACK (prefilled) cannot be produced from the provided prompt alone because supplier identity is SKU-specific and depends on the exact actives, strength, NDC, and manufacturing site.
- Supplier mapping should be built from SKU-level evidence (NDC label/manufacturing site codes, FDA drug establishment listings, and packaging/manufacturing disclosure in label and regulatory datasets).
FAQs
-
How can I identify the drug-product manufacturer for an OTC MONISTAT 3 prefilling SKU?
From the carton and tube label: manufacturing site name/address, labeler, and NDC. Those fields map to FDA drug establishment records.
-
Do API suppliers for OTC vaginal antifungals stay constant across retail “combination packs”?
Not reliably. Retail bundling and applicator formats often shift manufacturing and packaging contractors.
-
What supply chain roles exist for prefilling applicators?
Applicator component suppliers, prefill/fill-finish contractors, and secondary packagers assembling combination packs.
-
Where do suppliers show up besides the ingredient list on the package?
NDC label sections, “manufactured for” / “distributed by” lines, and the manufacturing address fields on cartons.
-
How do I validate whether a supplier made the finished prefills versus only assembled cartons?
Compare manufacturing-site fields for the finished drug-product and separately check packer/labeler identifiers tied to the combination pack’s NDC.
References
No sources were cited because no SKU-specific supplier or regulatory-identification data was provided.
